Realcan's shareholder Jingzhou Huize plans to reduce its holdings by no more than 1%
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, Realcan announced that its shareholder Jingzhou Zhaoshang Huize Pharmaceutical Investment Partnership (Limited Partnership) plans to reduce its holdings in the company by no more than 15.0471 million shares through centralized bidding or block trading, which is no more than 1% of the company's total share capital
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments